Connect Corporate Finance assisted a global logistics business with their acquisition of a European specialist logistics provider.

We recently assisted the deal team of a global logistics group with the acquisition of a multi-country European logistics business specialising in time-critical, temperature-sensitive and high-value shipments.

The target company provides logistics solutions for life sciences, pharmaceutical and other sensitive cargo sectors, supporting the transportation of clinical trial materials, pharmaceutical products and other high-value shipments requiring controlled handling procedures.

With extensive experience in temperature-controlled logistics and regulatory compliance, the vendor delivers secure and compliant solutions through to final delivery.

Connect Corporate Finance supported its client on a pan-European basis, identifying highly specialised and strategically compatible acquisition opportunities. The transaction represented a strong strategic fit, with both businesses sharing deep expertise in highly specialised industry verticals where service quality, operational precision and time-critical execution are central to customer requirements.

Our client successfully completed the acquisition in Q1 2026.